Wednesday, 3 June 2015

Don’t Call Me Jim Cramer but Here are My Top 5 Pharma Trends

ads

Pharmaceutical production costs are rising 
because companies have more hurdles 
to pass during the testing phase.
by Lane Hirning
Product Management Director, MasterControl Inc.

Judging by a recent report forecasting future growth, the pharmaceutical industry is thriving despite the recent economic downturn. A market research firm is estimating a 30 percent increase in global medicine spending by 2018, which is great news for the industry (1). The same report cited the anticipated launch of 200 new revenue-boosting drugs within the next five years.

Amid this robust growth, what are some of the things that you can look forward to in the near future? I was asked this question recently. Short of sounding like Jim Cramer of CNBC’s “Mad Money” fame, I picked the following trends as likely to influence pharma in the near term. They all have one thing in common—they reflect the impact of technology on medicine and the health-care process.

Do you agree with my picks? What would you add to the list? Leave a comment for me below.
READ MORE »

Don’t Call Me Jim Cramer but Here are My Top 5 Pharma Trends Rating: 4.5 Diposkan Oleh: Unknown

 

Top